New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 9, 2014
05:16 EDTZGNXZogenix requested order staying the ban of Zohydro in MA
Today Zogenix presented its case in U.S. District Court in Boston requesting an immediate order staying the ban on the FDA-approved prescription drug product, Zohydro ER extended-release capsules, entered on March 27, by Massachusetts Governor Deval Patrick. A follow-up hearing has been scheduled for Monday, April 14. The company will continue to monitor, evaluate and take appropriate actions in all states specific to Zohydro ER to ensure that all FDA-approved Schedule II prescription opioids covered by the FDA mandated Risk Evaluation Mitigation Strategy for extended-release and long-acting opioid analgesics receive equal treatment for any rules that impact patient access and prescribing.
News For ZGNX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 31, 2014
08:40 EDTZGNXZogenix, Purdue Pharma exchange waivers of exclusivity for hydrocodone products
Subscribe for More Information
October 27, 2014
16:28 EDTZGNXVisium Asset Management reports 5.3% passive stake in Zogenix
07:34 EDTZGNXZogenix acquires Brabant Pharma for $20M cash, $15M in stock
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use